Trading volume was 19.9 times its 30-day average, The stock rose 10.2 percent so far this year.
Shares of the drugmaker rose as much as 8.7 percent, the most in over a year, to trade near a two-month high at Rs 2,655.
A court in U.S. ruling allowed the pharmaceutical company to sell a generic of Indivior Plc’s opioid treatment drug Suboxone, according to a NBR report.
